SelectMDx is a Post-DRE, First-Catch urine test that utilizes two genes commonly expressed in CSPCa

SelectMDx can help providers distinguish patients at increased risk for CSPCa from those at very low risk for aggressive disease

SelectMDx is for any man with an abnormal PSA &/or DRE who you are considering for additional workup or a referral to a urologist

SelectMDx offers a binary, actionable report

SelectMDx negative, is labeled Very Low Risk

SelectMDx’s Power is in the negative

SelectMDx has a Negative Predictive Value of 95% for GS ≥ 7 & >99% for GS ≥8. What this means to you is that when you do receive a negative:

• You can feel confident this patient has a very low likelihood of harboring CSPCa at this time

• You can offer your patient some peace of mind

• You can potentially decide to just monitor his PSA

SelectMDx positive offers a Personalized Risk Profile. A SelectMDx positive

result means:

• This patient is at Increased Risk of harboring CSPCa

• This is a patient you may want to prioritize in your diagnostic process/ protocol

• This is a patient who you may want to refer to urology for additional workup

The Vast Majority of patients will pay $100 or less for SelectMDx

SelectMDx is included in the NCCN Guidelines